AndroGel is a topical hormone marketed to men experiencing complications from low levels of natural testosterone. AndroGel was heavily promoted by Abbott Laboratories and AbbVie Inc., with the companies selling the product through testimony from retired professional athletes. Abbott Laboratories and AbbVie Inc. also provided statistics and fed positive reports…
Product Liability Lawyer Blog
Major Chicken Provider Shut Down for Unsanitary Conditions
Foster Farms, a chicken processing plant in California, didn’t open re-open its doors last week after it was shut down by officials because of an alleged cockroach infestation, report NBC. Officials with the company state that they needed more time to address the problem before opening in good faith. Officials…
Actos Bladder Cancer Bellwether Trial Begins
A federal jury is preparing to hear a bellwether case regarding the alleged cancer-causing diabetes drug Actos, manufactured by Asia’s largest drugmaker, Takeda Pharmaceuticals. The plaintiff in Terrence Allen et ux. v. Takeda Pharmaceuticals North America Inc. et al alleges damages in excess of $75,000 after he says he developed…
Maine’s Relaxed Import Drug Law & Risk of Dangerous Drugs
Concerns regarding defective drugs in New England are heightened, following Maine’s recent passage of a law that allows residents there to import prescription drugs from overseas. The policy’s staunch critics include the Pharmaceutical Research and Manufacturer’s of America, the Maine Pharmacy Association and big-name drug manufacturers such as Pfizer and…
CT Scans: Benefits Outweigh the Risks?
As researchers continue to search for the cure for cancer, it continues to impact families across the nation. Officials believe that it may soon surpass heart disease as the leading cause of death in the U.S. According to The New York Times, one of the most alarming culprits of this…
Biomet Looks Ahead as Defective Hip Cases Move Forward
Biomet recently announced its financial results for the second quarter, indicating an increase in consolidated net sales and announcing the commercial launch of the company’s G7™ Acetabular System in 2014. The financial release indicated that the report contained forward looking statements and that the company’s actual results could be affected…
Leukemia Drug Iclusig Expected to Resume Marketing Amid Safety Concerns
A new leukemia drug hit the market last year – and approval was promptly suspended by the U.S. Food and Drug Administration amid concerns that it caused the potential for life-threatening blood clots and a severe restriction of the blood vessels. The drug, known as Iclusig and ponatinib, has reportedly…
Acetaminophen Dangers Highlighted in Recent Reports
Acetaminophen is far and away considered one of the safest drugs on the market. It’s the active ingredient in Tylenol, and tens of millions of people take this popular pain reliever and fever reducer every week with no major problems. But did you know that over the last 10 years,…
Faulty Hip Replacements Result in $56 Million Settlement from Biomet
Biomet Inc., a medical device manufacturer based in the U.S., has agreed to pay a minimum of $56 million in order to settle a multi-district lawsuit stemming from defective metal hip replacements. Court filings in the case of In Re: Biomet M2A Magnum Hip Implant Products Liability Litigation, from the…
Report: FDA-Approval Doesn’t Guarantee Drug Safety
While the U.S. Food and Drug Administration offers its stamp of approval on a wide range of medications and treatments each year, that green light is no guarantee that a drug won’t be harmful. A recent annual report by the Institute for Safe Medication Practices revealed that there was a…